You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LTBI

Showing 1 - 25 of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Latent Tuberculosis Trial (CDC/NTCA guidelines only, LTBI ASSIST and CDC/NTCA guidelines only)

Not yet recruiting
  • Latent Tuberculosis
  • CDC/NTCA guidelines only
  • LTBI ASSIST and CDC/NTCA guidelines only
  • (no location specified)
Mar 7, 2023

Latent Tuberculosis, Diabetes, Type 2 Trial in Copenhagen (Rifampicin 300 Mg Oral Capsule, Isoniazid 300 Mg ORAL TABLET)

Recruiting
  • Latent Tuberculosis
  • Diabetes Mellitus, Type 2
  • Rifampicin 300 Mg Oral Capsule
  • Isoniazid 300 Mg ORAL TABLET
  • Copenhagen, Denmark
    Herlev-Gentofte Hospital
Aug 3, 2022

Latent Tuberculosis Trial in Pasadena (LTBI video intervention)

Recruiting
  • Latent Tuberculosis
  • LTBI video intervention
  • Pasadena, California
    Kaiser Permanente Southern California Department of Research and
Jun 16, 2022

Latent Tuberculosis Infection Trial in Taipei (isoniazid and rifapentine)

Recruiting
  • Latent Tuberculosis Infection
  • isoniazid and rifapentine
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 22, 2022

Latent Tuberculosis Infection Trial in Columbia (BST, TST, QFT)

Active, not recruiting
Has Results
  • Latent Tuberculosis Infection
  • Columbia, South Carolina
    Fort Jackson, SC
Dec 16, 2021

BCG Vaccination in Neonates Born to HIV and LTBI Infected and

Completed
  • HIV Infections
  • +3 more
  • RNAseq
  • Chisinau, Moldova, Republic of
  • +1 more
Oct 19, 2021

Malnutrition, Diabetes Mellitus, and Helminth Infections on

Active, not recruiting
  • Mycobacterium Tuberculosis
  • +4 more
    • Chennai, India
      National Institute for Research In Tuberculosis, International C
    Jul 28, 2022

    Healthy, Latent Tuberculosis Infection (LTBI) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Tuberculin

    Recruiting
    • Healthy
    • Latent Tuberculosis Infection (LTBI)
    • Tuberculin Purified Protein Derivative
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 22, 2022

    Latent Tuberculosis Trial in London (Community/Primary Care, Hospital/TB Clinic)

    Completed
    • Latent Tuberculosis
    • Community/Primary Care
    • Hospital/TB Clinic
    • London, United Kingdom
      Shrewsbury Road Health Centre
    Nov 24, 2021

    Latent Tuberculosis Trial in Bangkok (TST vs PPD microneedle test)

    Recruiting
    • Latent Tuberculosis
    • TST vs PPD microneedle test
    • Bangkok, Thailand
      Faculty of Medicine, Chulalongkorn University
    Aug 23, 2021

    LTBI, BCG Vaccination Reaction, TB Trial in Prague (Blood draw)

    Recruiting
    • LTBI
    • +2 more
    • Blood draw
    • Prague, Czechia
    • +1 more
    Dec 12, 2020

    Tuberculosis, Latent Tuberculosis Infection Trial in San Diego (Video Directly Observed Therapy, In-Person DOT)

    Completed
    • Tuberculosis
    • Latent Tuberculosis Infection
    • Video Directly Observed Therapy
    • In-Person DOT
    • San Diego, California
      San Diego County Health and Human Services Agency
    Feb 2, 2021

    Compliance, Patient Trial in Aarhus, Esbjerg (Rifapentine, Isoniazid)

    Recruiting
    • Compliance, Patient
    • Aarhus, Denmark
    • +1 more
    Jul 26, 2021

    Respiratory Tract Infections, HIV Trial in Tembisa (3HP plus DTG +2NRTIs)

    Recruiting
    • Respiratory Tract Infections
    • HIV Infections
    • 3HP plus DTG +2NRTIs
    • Tembisa, Gauteng, South Africa
      The Aurum Institute: Tembisa Clinical Research Centre
    Sep 7, 2021

    Latent Tuberculosis in Healthcare Workers - Reality ofPortuguese

    Recruiting
    • Tuberculosis
    • IGRA/Tuberculin skin test
    • Torres Vedras, Lisboa, Portugal
      Centro Hospitalar do Oeste - Torres Vedras
    Apr 27, 2023

    Latent Tuberculosis Infection in Health-care Workers and

    Recruiting
    • Tuberculosis
    • +4 more
    • Prevalence of Latent Tuberculosis Infection
    • Roma, Italy
      UOSD Allergologia e Immunologia Clinica, Fondazione Policlinico
    Mar 1, 2023

    Tuberculosis Trial in San Francisco (Isoniazid, Rifampin)

    Completed
    Has Results
    • Tuberculosis
    • San Francisco, California
      University of California San Francisco
    Jul 13, 2020

    Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis Trial in Malmö

    Recruiting
    • Latent Tuberculosis
    • +2 more
      • Malmö, Skåne, Sweden
        Skåne University Hospital
      Nov 10, 2022

      Latent Tuberculosis, Diabete Mellitus, Malnutrition Trial in Chennai

      Recruiting
      • Latent Tuberculosis
      • +3 more
        • Chennai, Tamilnadu, India
          National Institute for Research in Tuberculosis
        Jul 6, 2022

        Pulmonology Trial in Taipei (Rifamycin-containing regimen, Rifamycin-free regimen)

        Recruiting
        • Pulmonology
        • Rifamycin-containing regimen
        • Rifamycin-free regimen
        • Taipei, Taiwan
          National Taiwan University Hospital
        Oct 18, 2022

        Latent Tuberculosis Trial in Pawtucket (TB Infection ECHO)

        Active, not recruiting
        • Latent Tuberculosis
        • TB Infection ECHO
        • Pawtucket, Rhode Island
          Brown Family Medicine Department
        Mar 26, 2022

        Methods in People Living With Retroviral Infection in Liberia

        Active, not recruiting
        • Tuberculosis
        • HIV
          • Bethesda, Maryland
          • +4 more
          Jan 14, 2023

          Latent Tuberculosis Trial in London (IGRA blood test used as a tool for opt-out screening for latent Tuberculsis infection)

          Active, not recruiting
          • Latent Tuberculosis
          • IGRA blood test used as a tool for opt-out screening for latent Tuberculsis infection
          • London, Essex, United Kingdom
          • +2 more
          Sep 21, 2021

          HIV-infected Participants With Latent TB Infection in High TB Burden Country Trial in Thailand (Isoniazid/Rifapentine daily (4

          Recruiting
          • HIV-infected Participants With Latent TB Infection in High TB Burden Country
          • Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)
          • Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)
          • Bangkok, Thailand
          • +15 more
          Mar 22, 2022

          Tuberculosis Trial (Quantiferon Gold, HIV serology, Respiratory secretion culture (sputum or gastric aspirate_)

          Not yet recruiting
          • Tuberculosis
          • Quantiferon Gold
          • +5 more
          • (no location specified)
          Oct 27, 2023